These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885 [TBL] [Abstract][Full Text] [Related]
4. Nipple aspirate fluid color is associated with breast cancer. Sauter ER; Winn JN; Dale PS; Wagner-Mann C Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197 [TBL] [Abstract][Full Text] [Related]
5. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies. Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487 [TBL] [Abstract][Full Text] [Related]
6. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of terminal duct lobular units and frequency of neoplastic involvement of the nipple in mastectomy. Kryvenko ON; Yoon JY; Chitale DA; Lee MW Arch Pathol Lab Med; 2013 Jul; 137(7):955-60. PubMed ID: 23808467 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Sauter ER; Klein G; Wagner-Mann C; Diamandis EP Cancer Detect Prev; 2004; 28(1):27-31. PubMed ID: 15041074 [TBL] [Abstract][Full Text] [Related]
9. Nipple involvement in breast cancer: retrospective analysis of 2323 consecutive mastectomy specimens. Weidong Li ; Shuling Wang ; Xiaojing Guo ; Ronggang Lang ; Yu Fan ; Feng Gu ; Xinmin Zhang ; Zhengmao Zhu ; Yun Niu ; Li Fu Int J Surg Pathol; 2011 Jun; 19(3):328-34. PubMed ID: 21454374 [TBL] [Abstract][Full Text] [Related]
10. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy]. Kósa C; Garami Z; Dinya T; Fülöp B Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391 [TBL] [Abstract][Full Text] [Related]
11. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Renshaw AA; Derhagopian RP; Martinez P; Gould EW Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208 [TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma]. Wang SY; Peng DF; Cai ZG; Zhang RZ; Yao TJ; Zhang H; Yang M; Dong HM Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937 [TBL] [Abstract][Full Text] [Related]
13. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy. Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632 [TBL] [Abstract][Full Text] [Related]
15. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851 [TBL] [Abstract][Full Text] [Related]
16. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery. Atalay C; Irkkan C Breast J; 2012; 18(4):339-44. PubMed ID: 22616572 [TBL] [Abstract][Full Text] [Related]
17. Breast conservative surgery and local recurrence. Rezai M; Kraemer S; Kimmig R; Kern P Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359 [TBL] [Abstract][Full Text] [Related]
18. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease? Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959 [TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma in situ in a male. Report of a case diagnosed by nipple discharge cytology. López-Ríos F; Vargas-Castrillón J; González-Palacios F; de Agustín PP Acta Cytol; 1998; 42(3):742-4. PubMed ID: 9622698 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy? Murthy V; Chamberlain RS Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]